Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSX: $ACB.TO,
NASDAQ: $CRON, TSX: $APH.TO, CSE: $MTEC.C, TSXV: $N.V
and #Stocks on the Move: TSX: $ACB.TO,
NASDAQ: $CRON, TSX: $APH.TO, CSE: $MTEC.C, TSXV: $N.V
Delta, Kelowna, BC –September 4, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the September 4 podcast:
Read this in full at https://www.investorideas.com/news/2018/cannabis/09042Potcasts-TSX-ACB-NASDAQ-CRON-APH-CSE-MTEC-N.asp
Transcript of Today’s Podcast
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Aurora Cannabis Inc.
trading on the TSX as ACB and the OTCQB as ACBFF, Cronos Group Inc. trading on
the NASDAQ and TSX as CRON, Aphria Inc. trading on the TSX as APH OTC as
APHQF, Cannvas MedTech Inc. trading on the CSE as MTEC and Namaste
Technologies Inc. trading on the TSX-Venture as N.
trading on the TSX as ACB and the OTCQB as ACBFF, Cronos Group Inc. trading on
the NASDAQ and TSX as CRON, Aphria Inc. trading on the TSX as APH OTC as
APHQF, Cannvas MedTech Inc. trading on the CSE as MTEC and Namaste
Technologies Inc. trading on the TSX-Venture as N.
Aurora Cannabis Inc. today announced that it has closed its previously
announced debt facility with the Bank of Montreal ("BMO"). The
facility consists of a $150 million term loan and a $50 million revolving
credit facility, both of which mature in 2021. Included in the facility is an
option to upsize the facility to $250 million total following the
implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO
and satisfaction of certain legal and business conditions.
announced debt facility with the Bank of Montreal ("BMO"). The
facility consists of a $150 million term loan and a $50 million revolving
credit facility, both of which mature in 2021. Included in the facility is an
option to upsize the facility to $250 million total following the
implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO
and satisfaction of certain legal and business conditions.
The debt facility is primarily secured by Aurora's production
facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie.
Strategically located at Edmonton International Airport, Aurora Sky is the
world's most technologically advanced cannabis facility, projected to produce
in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis
upon completion.
facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie.
Strategically located at Edmonton International Airport, Aurora Sky is the
world's most technologically advanced cannabis facility, projected to produce
in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis
upon completion.
Today, Cronos Group Inc., a geographically diversified and vertically
integrated cannabis group, and Ginkgo Bioworks Inc., the organism company,
announced a landmark partnership to produce cultured cannabinoids. Using its
platform technology for organism design and development, Ginkgo will complement
Cronos Group's technologies for producing a full spectrum of cannabinoids. As
part of this unprecedented deal, Cronos Group has agreed to issue a specific
number of common shares in tranches subject to Ginkgo's achievement of certain
production milestones.
integrated cannabis group, and Ginkgo Bioworks Inc., the organism company,
announced a landmark partnership to produce cultured cannabinoids. Using its
platform technology for organism design and development, Ginkgo will complement
Cronos Group's technologies for producing a full spectrum of cannabinoids. As
part of this unprecedented deal, Cronos Group has agreed to issue a specific
number of common shares in tranches subject to Ginkgo's achievement of certain
production milestones.
As two of the leading companies in their respective industries, Cronos
Group and Ginkgo believe that they are best-suited to unlock the potential of
innovation in the cannabis industry. Cronos Group brings a deep understanding
of the plant's biological structure and function, while Ginkgo brings 10 years
of experience designing microorganisms for the production of cultured products
across pharmaceuticals, agriculture, flavors, fragrances, and more.
Group and Ginkgo believe that they are best-suited to unlock the potential of
innovation in the cannabis industry. Cronos Group brings a deep understanding
of the plant's biological structure and function, while Ginkgo brings 10 years
of experience designing microorganisms for the production of cultured products
across pharmaceuticals, agriculture, flavors, fragrances, and more.
Cannabinoids span a range of molecules with different properties, and
ongoing research has demonstrated potential medicinal uses for indications such
as chronic pain, nervous disorders, nausea, weight loss, and some mental
illnesses. However, many pharmaceutically relevant cannabinoids are present
only at very low quantities in the cannabis plant, making them economically
impractical, difficult or impossible to extract at high purity and scale. The
landmark partnership between Cronos Group and Ginkgo will leverage the
expertise of both organizations to solve this challenge and make more
accessible the benefits of cannabinoids in an economically sustainable way.
ongoing research has demonstrated potential medicinal uses for indications such
as chronic pain, nervous disorders, nausea, weight loss, and some mental
illnesses. However, many pharmaceutically relevant cannabinoids are present
only at very low quantities in the cannabis plant, making them economically
impractical, difficult or impossible to extract at high purity and scale. The
landmark partnership between Cronos Group and Ginkgo will leverage the
expertise of both organizations to solve this challenge and make more
accessible the benefits of cannabinoids in an economically sustainable way.
Aphria Inc. today announced that it has entered into a strategic
partnership with Schroll Medical, a subsidiary of prominent European flower
producer, Schroll Flowers. The Partnership will pursue the cultivation and
worldwide distribution of organic, EU GMP-certified medical cannabis, and will
be managed by the Company's wholly-owned subsidiary Aphria Deutschland GmbH
("Aphria Germany").
The deal accelerates Aphria's global expansion, in collaboration with an
established and world-class partner, with first product expected to be
available by early 2019.
partnership with Schroll Medical, a subsidiary of prominent European flower
producer, Schroll Flowers. The Partnership will pursue the cultivation and
worldwide distribution of organic, EU GMP-certified medical cannabis, and will
be managed by the Company's wholly-owned subsidiary Aphria Deutschland GmbH
("Aphria Germany").
The deal accelerates Aphria's global expansion, in collaboration with an
established and world-class partner, with first product expected to be
available by early 2019.
In exchange for a 15% interest in the Partnership, Aphria is providing
€100,000 to the Partnership, its leadership in cannabis greenhouse cultivation
and experience in processing and worldwide distribution. This will include, but
is not limited to, consulting on GMP certification, cannabis genetics and
strains, and proprietary growing IP. Aphria will also handle the worldwide
distribution of medical cannabis produced by the Partnership, which is
anticipated to be made available to markets in Germany, Luxembourg, Switzerland
and other developing medical cannabis markets. As part of the deal, Aphria
maintains a path to increase its ownership interest to 50% and a path to
realize full liquidity, each under certain conditions.
€100,000 to the Partnership, its leadership in cannabis greenhouse cultivation
and experience in processing and worldwide distribution. This will include, but
is not limited to, consulting on GMP certification, cannabis genetics and
strains, and proprietary growing IP. Aphria will also handle the worldwide
distribution of medical cannabis produced by the Partnership, which is
anticipated to be made available to markets in Germany, Luxembourg, Switzerland
and other developing medical cannabis markets. As part of the deal, Aphria
maintains a path to increase its ownership interest to 50% and a path to
realize full liquidity, each under certain conditions.
Cannvas MedTech Inc., a leading business
technology company in the cannabis space, is pleased to announce its vendor of
choice for integration to its Artificial Intelligence (A.I) component powering
the Cannvas.me cannabis education platform.
technology company in the cannabis space, is pleased to announce its vendor of
choice for integration to its Artificial Intelligence (A.I) component powering
the Cannvas.me cannabis education platform.
IBM Watson has been chosen to power the A.I. analytics branch
of the Cannvas platform. It will serve as a best-in-class
integrated solution most relevant and attuned for the persona-driven
architecture of the platform. Leveraging IBMs A.I. service allows the
Cannvas team to quickly analyze through the copious amounts of data attributes
comprising the Cannvas.me platform in a relevant and real-time fashion for its
user base.
of the Cannvas platform. It will serve as a best-in-class
integrated solution most relevant and attuned for the persona-driven
architecture of the platform. Leveraging IBMs A.I. service allows the
Cannvas team to quickly analyze through the copious amounts of data attributes
comprising the Cannvas.me platform in a relevant and real-time fashion for its
user base.
Deriving industry and customer insights in a real-time fashion for the
CRM program requires the use of technologies that are at the leading edge of
their space. Utilizing IBM Watsons capabilities allows the Cannvas
technology stack to achieve this goal. Cannvas.me takes the
traditional Email Customer Journey and transforms it into a true Omni-Channel
approach where user preferences and insights are utilized to serve a fully
personalized message experience through the channel of their choice. Cannvas.me
will be able to truly embrace the concept of Omni-Channel marketing.
CRM program requires the use of technologies that are at the leading edge of
their space. Utilizing IBM Watsons capabilities allows the Cannvas
technology stack to achieve this goal. Cannvas.me takes the
traditional Email Customer Journey and transforms it into a true Omni-Channel
approach where user preferences and insights are utilized to serve a fully
personalized message experience through the channel of their choice. Cannvas.me
will be able to truly embrace the concept of Omni-Channel marketing.
Namaste Technologies Inc. announced that the Company has signed a
veteran patient services agreement and a medical cannabis supply agreement with
Breton CannaPharms Ltd. Breton CannaPharms has a very strong presence in
veteran communities across Canada and the entire management team has extensive
experience in holistically servicing veterans and educating communities on the
positive and misunderstood effects of medical cannabis to treat veterans
suffering from both chronic pain and post-traumatic stress disorder
("PTSD").
veteran patient services agreement and a medical cannabis supply agreement with
Breton CannaPharms Ltd. Breton CannaPharms has a very strong presence in
veteran communities across Canada and the entire management team has extensive
experience in holistically servicing veterans and educating communities on the
positive and misunderstood effects of medical cannabis to treat veterans
suffering from both chronic pain and post-traumatic stress disorder
("PTSD").
Under the terms of the Patient Services Agreement, Breton Farms will
work exclusively with NamasteMD to target patient acquisition within veteran
groups across the country. Namaste is proud to partner with Breton Cannabis to
focus on acquiring veteran patients and servicing their needs through its
Access to Cannabis for Medical Purposes Regulations ("ACMRP")
Licensed Producer partners. NamasteMD provides convenient access to nurse
practitioners for medical consultations through online video and is available
on the Apple Store, Google Play devices and online at NamasteMD.com.
work exclusively with NamasteMD to target patient acquisition within veteran
groups across the country. Namaste is proud to partner with Breton Cannabis to
focus on acquiring veteran patients and servicing their needs through its
Access to Cannabis for Medical Purposes Regulations ("ACMRP")
Licensed Producer partners. NamasteMD provides convenient access to nurse
practitioners for medical consultations through online video and is available
on the Apple Store, Google Play devices and online at NamasteMD.com.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Potcasts is now a certified word mark Trademark on the blockchain through
Cognate, Inc. CM Certification
Cognate, Inc. CM Certification
Investorideas.com podcasts are also available on iTunes, Spotify,
Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
If you would like to be a guest or sponsor this podcast contact
Investorideas.com
Investorideas.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
